Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study.
José M Álvaro-GraciaCarlos Sanchez-PiedraDante CulquiRosa RoselloAlicia Garcia-DortaCristina CamposSara Manrique ArijaDolores Ruiz-MontesinosInmaculada Ros-VilamajoCarlos Rodríguez-LozanoMercedes Freire-GonzálezRafael CalizCristina BohorquezLourdes Mateo SoriaNoemí BusquetsIsabel CastrejonFernando Sánchez-AlonsoEnrique González-DávilaFederico Díaz-GonzálezPublished in: RMD open (2023)
COVID-19 vaccination was not associated with increased rate of flares in patients with RA and PsA. However, a potential increase in disease activity in patients with RA treated with JAK-i and IL-6-i and in patients with PsA treated with IL-12/23-i warrants further investigation.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- coronavirus disease
- rheumatoid arthritis patients
- prostate cancer
- sars cov
- ankylosing spondylitis
- juvenile idiopathic arthritis
- radical prostatectomy
- respiratory syndrome coronavirus
- interstitial lung disease
- systemic sclerosis
- idiopathic pulmonary fibrosis